-
A 40-year-old Gambian male with end-stage renal disease secondary to focal segmental glomerulosclerosis (FSGS) was evaluated for a living unrelated kidney transplant.
-
In this issue: New recommendations for HPV vaccine; guidelines for treatment of essential tremor; updates on smoking cessation drugs; and FDA actions.
-
Since the time of the roman empire the animal virus, rinderpest (RPV), German for "cattle plague," has led to countless human deaths from agricultural losses that resulted in famine and disease.
-
An outbreak of dengue fever in northeastern kenya was first reported in September 2011, and is believed to be spreading rapidly, with at least 5,000 people infected within the first weeks of this outbreak.
-
Approximately 2 million children cross internation-al borders each year, and many of them are traveling with older family members to visit friends and relatives (VFR) in the family's country of origin. Previous studies suggest that these children are at particular risk of missing potentially helpful pre-travel interventions and of becoming ill during travel.
-
Greek health authorities recently published their findings of 36 cases of Plasmodium vivax malaria in Greece occurring between May 2011 and September 2011.
-
-
Vaccination has dramatically reduced the number of cases of chickenpox, measles, polio, mumps, and pertussis treated in primary care settings. Antibiotic treatment of streptococcal pharyngitis has reduced the number of cases of rheumatic fever. As a result, there are generations of physicians who have never encountered patients with these diseases. These diseases are often relegated to the historical section of general medical textbooks. However, recent isolated outbreaks in adults as well as children have brought these diseases back into the forefront for primary care providers.
-
The authors conclude that this large observational study suggests ACEI or ARB therapy is associated with an improved survival and a lower risk of cardiovascular events in patients with aortic stenosis.
-
A kinase inhibitor for late-stage melanoma and its companion diagnostic test have been approved by the FDA.
